clinical trial · NCT05896254
Study of MAR001 in Adults With Metabolic Dysfunction
HypertriglyceridemiaMAR001Placebo
brief summary
The purpose of this study is to evaluate the safety and tolerability of multiple doses of MAR001in adult volunteers with metabolic dysfunction.
started
Jul 22, 2023
primary completion
Dec 13, 2024
completion
Dec 13, 2024
last updated
Nov 13, 2025
official title
A Phase 1b/2a Randomized, Double-Blind, Placebo-controlled Study of the Safety and Efficacy of MAR001 in Patients With Metabolic Dysfunction
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol